Antimicrobial Stewardship

Ebola

HCV / Hepatitis

Blood-Borne Diseases

Climate Change

Coronavirus

Covid Vaccine Race

E. Coli

Food Safety

Listeria

Salmonella

Food Borne Infection / Food Safety

Fungal Infections

C. Difficile

H. Pylori

Norovirus

Gastrointestinal Infections

Healthcare Associated Infections (HAI)

Antibiotics

Immunizations

Vaccines

Prevention

Community-Acquired Pneumonia 

HAP / VAP

Influenza

Respiratory Infections

HIV / AIDS

PrEP

Sexually Transmitted Diseases

MRSA

Skin & Soft Tissue Diseases

Lyme Disease

ZIKA

Zoonotic & Vector-Borne Diseases

News

Media

Medical World News

Podcasts

Videos

Insights

Peer Exchange

News Network

Roundtables

Conference

Conference Coverage

Conference Listing

Publication

CME/CE

Partners

Resources

Interactive Tools

Special Projects

Contribute

Case Studies

Writers and Mentors

Subscribe

Contagion® is a fully integrated news resource for practitioners and specialists to assist with the identification, diagnosis, treatment, and prevention of infectious diseases.

About Us

Advertise

Editorial

Contact Us

Do Not Sell My Information

Privacy

Terms & Conditions

Contagion Live | Infectious Disease News & Expert Insights

Facebook

LinkedIn

Spotlight

Bench to Bedside With SIDP

C. difficile 

Clinical Corner

Hepatitis

RSV: A New Era in Prevention

Clinical

COVID-19

Food-Borne Infections

Healthcare-Associated Infections

Respiratory Diseases

Respiratory Syncytial Virus (RSV)

Video Series

Peers and Perspectives

1rem

Continuing Education

Gary S. Marshall, MD; Shanna M. Barton, MD; Theresa M. Fiorito, MD

Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations

Surya Bhatt, MD, MSPH; Stephanie A. Christenson, MD, MAS 

Shaping the Management of COPD with Biologic Therapy

Anita Clayton, MD; John J. Miller, MD; Sanjai Rao, MD, DFAPA

2023 Annual Psychiatric Times™ World CME Conference

Jessica Ailani, MD, FAHS, FAAN; Richard S. Isaacson, MD; Stephen Krieger, MD, FAAN; Rory M. C. Abrams, MD; Laxman Bahroo, DO; Richard S. Bedlack Jr, MD, PhD, MS; Patricia K. Coyle, MD; Gayatri Devi, MD, MS, FACP, FAAN; Patricia Dugan, MD, FAES; Mazen Elkurd, DO; Jill Farmer, DO, MPH; Jennifer A. Frontera, MD; Saadi Ghatan, MD, FACS; Jihan A. Grant, MD; Stuart Isaacson, MD, FAAN; Steven E. Lo, MD; Erin Longbrake, MD, PhD; Lara V. Marcuse, MD; Kara R. Melmed, MD; Matthew Schrag, MD, PhD; Stewart Tepper, MD;

5th Annual International Congress on the Future of Neurology®

Cheryl Pirozzi, MD, MS; Charlie Strange, MD

Let’s Get “Real”: Alpha-1 Antitrypsin Deficiency—Case-Based Perspectives on Managing Associated Emphysema

Ritu Salani, MD, MBA; Bradley J. Monk, MD, FACS, FACOG. Kathleen Moore, MD, MS

Medical Crossfire®: Finding The Right Place for Immunotherapy and Targeted Treatments in the Management of Endometrial Cancer

Richard Channick, MD; Josanna Rodriguez-Lopez, MD

Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes

Catherine M. Broome, MD; Jamile Shammo, MD, FASCP, FACP

Cases and Conversations™: Applying Guidelines to Practice for the Management of Paroxysmal Nocturnal Hemoglobinuria

Melissa Barnett, OD, FAAO, FSLS, FBCLA; Vin T. Dang, OD, FAAO; Cecelia Koetting, OD, FAAO, DipABO

(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action

Balazs Halmos, MD, MS; Kristen K. Ciombor, MD, MSCI; Joyce O’Shaughnessy, MD; Daniel P. Petrylak, MD 

Community Practice Connections™: Clinical Updates from Chicago – A Focus on What Community Centers Need to Know to Move Their Solid Tumors' Practices Forward

Maurie Markman, MD; Rachel N. Grisham, MD; Bhavana Pothuri, MD

  Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

Howard I. Scher, MD; Scott T. Tagawa, MD, MS, FACP; Mary-Ellen Taplin, MD

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

Leslie Citrome, MD, MPH; Roger S. McIntyre MD, FRCPC

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

Andre H. Goy, MD; Sandra M. Swain, MD, FACP, FASCO Associate Dean for Research; Carolina Bernabe Ramirez, MD; Jonathan E. Rosenberg, MD; David H. Vesole, MD, PhD, FACP Director, Myeloma Program; Isabel Preeshagul, DO, MBS  
 

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

Oncology Briefings™: Selecting Therapy for Patients with Heavily Pretreated Myeloma Based on Patient and Disease-Specific Factors

Scott T. Tagawa, MD, MS, FACP; David M. Nanus, MD; Susan F. Slovin, MD, PhD

Medical Crossfire®:  How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?

Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia

Richard Lafayette, MD, FACP; Jai Radhakrishnan, MD

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

Vivek Subbiah, MD; Brian A. Van Tine, MD, PhD

Tumor Agnostic Trials and the Reshaping of Precision Medicine in Oncology: A Focus on TSC1/2 Mutations

Community Practice Connections™: Optimize the Diagnosis and Treatment of HER2-Positive Colorectal Cancer

Justin Schweitzer, OD, FAAO; Thomas Chester, OD, FAAO; Danica Marrelli, OD, FAAO

Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)

Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)

Nicholas J. Silvestri, MD; James F. Howard Jr, MD

Advances In™ Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management

Oncology Briefings™: Case Discussions in Smoldering Myeloma—To Treat or Not to Treat? 

Matthias A. Karajannis, MD, MS; Shannon Langmead, MSN, CRNP, CNRN, RN; Kate A. Mazur, MSN, APRN, CPNP-PC

Medical Crossfire®: How Has the Nurse’s Role Evolved in the Management of Pediatric Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas?

Jacqueline M. Kraveka, DO, Todd Michael Cooper, DO; Christopher Dvorak, MD; Kelly C. Goldsmith, MD; Michelle Hudspeth, MD; Stephen P. Hunger, MD; Michael Isakoff, MD; Kara Kelly, MD; Devorah Segal, MD, PhD; Verena Staedtke, MD, PhD; David T. Teachey, MD; Maria C. Velez-Yanguas, MD; Janet Yoon, MD  

2nd Annual International Congress on Pediatric Oncology

Community Practice Connections™: How Can We Optimize the Real World Application of BCMA-Targeted Therapies for Our Patients with R/R Multiple Myeloma?

(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action

Andre H. Goy, MD; Narjust Florez, MD; Monique Hartley-Brown, MD, MMSc (Guest Co-Chair)

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

Community Oncology Connections™: Controversies and Conversations About HER2-Expressing Breast Cancer… Advances in Management from HER2-Low to Positive Disease

Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis

Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer

Annual Hematology Meeting: Preceding the 66th ASH Annual Meeting and Exposition

Anisha Dua, MD, MPH; Praveen Akuthota, MD; Philip Seo, MD, MHS

EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care

Alison Bailey, MD, FACC; Jennifer Green, MD; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES; Robert F. Kushner, MD, MS, DABOM, FTOS, FACP; Erin Michos, MD, MHS, FACC, FAHA, FASPC, FA; Joshua Neumiller, PharmD, CDCES; Neha Pagidipati, MD, MPH; Biff Palmer, MD; Nosheen Reza, MD, FACC, FHFSA

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

Lynette M. Sholl, MD; Jason Chang, MD; Sonam Puri, MD 

Identifying Actionable Biomarkers in NSCLC: Real World Case Discussions on Applications of Testing in the Treatment Planning Process

Lucia M. Novak, MSN, ANP-BC, BC-ADM; Egils Bogdanovics, MD; Javier Morales, MD, FACP, FACE

Cases and Conversations™: Guideline Recommendations for the Use of Basal Insulin Therapy in Type 2 Diabetes

 Medical Crossfire®: Improving Survival in HR-Positive HER2 Negative Metastatic Breast Cancer – Advances in Estrogen Receptor Targeting Therapies

David Planchard, MD, PhD; Martin F. Dietrich, MD, PhD

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

Andrea M. Haqq, MD, MHS; Jesse Richards, DO, DABOM

Advances In™ Rare Genetic Forms of Obesity: Emerging Therapeutic Targets

Arshad M. Khanani, MD, MA, FASRS; Ferhina Ali, MD, MPH; Michael A. Singer, MD

Advancing Treatment in Neovascular Retinal Disease with Novel Therapies: Insights and Strategies from Latest Real-World and Clinical Data

Navigating the Next Wave in BTK Inhibition Strategies: Maximizing Clinical Benefit in CLL and MCL, What’s Next in B-Cell Malignancies

Tanios S. Bekaii-Saab, MD; Kristen K. Ciombor, MD, MSCI; Samuel Klempner, MD; Eileen O'Reilly, MD; Rachna Shroff , MD, MS

Community Practice Connections™: 20th Annual Meeting of the International Society of Gastrointestinal Oncology®

Hanny Al-Samkari, MD; Kevin H.M. Kuo, MD, MSc, FRCPC

Patient, Provider, and Caregiver Connection™: Developing Strategies to Improve Patient Access to Care for Thalassemia - Understanding Patient Challenges and the Role of Innovative Treatment

David Carbone, MD, PhD; Neel P. Chudgar, MD; Daniel Gomez, MD, MBA; Jianjun Zhang, MD, PhD

Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC

Benjamin P. Levy, MD; Komal Jhaveri, MD, FACP; Joshua K. Sabari, MD

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

Leslie Citrome, MD, MPH; Joseph F Goldberg, MD; Manish Kumar Jha, MBBS

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression –  Making the Case for Early Detection and Novel Treatments

Biree Andemariam, MD; Lydia H. Pecker, MD, MHS; Nirmish Shah, MD

Comprehensive Approaches to Creating Successful Sickle Cell Management Plans Across Patients’ Lifespans

Leslie Citrome, MD, MPH; Charles Brendan Montano, MD

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

Stephen Krieger, MD, FAAN; Mitzi Joi Williams, MD, FAAN; Frauke Zipp, MD

Community Practice Connections™: Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer

Burst CME: Optimizing Therapy in Parkinson’s Disease

Anita Afzali, MD, MPH, MHCM; Millie D. Long, MD, MPH


Working Group: Streamlining the Pathway from Diagnosis to Treatment in Inflammatory Bowel Disease

Arvind N. Dasari, MD; Cathy Eng, MD, FACP, FASCO 

Advances In™: The Evolving Role of VEGFR in the Treatment of Refractory mCRC

Joyce O’Shaughnessy, MD; Aditya Bardia, MD, MPH; Kevin Kalinsky, MD, MS; Tiffany A. Traina, MD

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

Lyudmila A. Bazhenova, MD; Julia Rotow, MD; Catherine A. Shu, MD

Matching Treatment to Patient with EGFR-Mutant Lung Cancer: Mutation Subtypes, Co-Mutations, and Managing Resistance

Improving Outcomes Across Frontline and R/R SCLC Care in Community Treatment Settings

Rapid Reviews in Retina™: Emerging Updates from Fall 2023 – Addressing the Wealth of New Data in Treatments for nAMD and DME

Nicole Lamanna, MD; Catherine C. Coombs, MD;  William Wierda, M.D., PhD; Jennifer A. Woyach, MD

Oncology Town Hall™: Primary Investigators Present Key Abstracts in CLL from San Diego

James F. Howard Jr, MD; Nicholas J. Silvestri, MD

Burst Expert Illustrations & Commentary™ : Visualizing the Role of the Complement Proteins in Neurologic Disorders

Dawn Jacob Laney, MS, CGC, CCRC; Eric Wallace, MD, FASN

‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease

Jakai D. Nolan, DO, MPH; Mitzi Joi Williams, MD, FAAN

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

Burst Expert Illustrations & Commentary™: Visualizing the Implications of Anti-Complement Therapies on Generalized Myasthenia Gravis

Understanding the Recent Developments in Myelodysplastic Syndromes (MDS)

 Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

William J. Gradishar, MD, FASCO, FACP; David M. Schuster, MD; Eleanor Harris, MD; Joseph A. Sparano, MD

Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings

Focusing on Key Updates on the Outlook of Acute Lymphocytic Leukemia (ALL) Management

Burst Expert Illustrations & Commentary™:  Visualizing the Role of the Complement Pathway in Neurological Disorders

Naval G. Daver, MD; Courtney D. DiNardo, MD, MSCE; Amir T. Fathi, MD; Gail J. Roboz, MD; Eytan M. Stein, MD

Upcoming CME Events & Activities

EVENTS

ACTIVITIES